Price $12.45 |
Market Cap
676.6M
|
Sector Health Care |
Div. Growth
-
|
|
P/E
656.5
|
P/B
6.19
|
P/S
5.78
|
Dividend %
-
|
|
P/CF
126.2
|
P/FCF
21.5
|
Op. Cash Flow
33.5K
|
FCF
0.6
|
|
Op. Margin
7.20%
|
Net Margin
3.00%
|
ROE
3.80%
|
ROI
15.00%
|
|
ROA
1.70%
|
EPS Growth
109.20%
|
Current Ratio
4.8
|
Debt/Equity
29.00%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Aytu Bioscience Inc (AYTU) | $0.22 | - | - | 6.7M | Strong Buy |
| iCAD Inc (ICAD) | $3.67 | - | - | 64.7M | Strong Buy |
| Misonix, Inc. (MSON) | $9.70 | - | - | 75.8M | Strong Buy |
| Aralez Pharmaceuticals Inc (ARLZ) | $1.08 | - | - | 81.6M | Strong Buy |
| Catasys, Inc. (CATS) | $4.67 | - | - | 68.9M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
